Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gustoeson May 17, 2019 11:57am

111 Views

Post# 29755774

RE:RE:OSC Notice to Public

So strange. Leverage in negotiations would be my guess? Anyone else have ideas?

Pandora wrote: So they put out a $10M shelf prospectus and then pull it back. A while later they put out a $100M shelf prospectus and now pull it back. What kind of a story can we derive from this? Is there a finance logic of some kind?

Eoganacht wrote: Just to be sure, I checked the Project Number - 2906418 - of the withdrawn prospectus. This is from the OSC Bulletin of May 2:

The Ontario Securities Commission

OSC Bulletin

May 2, 2019
Volume 42, Issue 18
(2019), 42 OSCB

Issuer Name:
Theralase Technologies Inc.
Principal Regulator – Ontario
Type and Date:
Preliminary Shelf Prospectus dated April 26, 2019
NP 11-202 Preliminary Receipt dated April 29, 2019
Offering Price and Description:
$100,000,000.00
Common Shares
Warrants
Units
Subscription Receipts

Underwriter(s) or Distributor(s): –
Promoter(s): –
Project #2906418

OSC Bulletin Link